☰

Bryan P. Burke, Ph.D. - Publications

Affiliations: 
2007 University of California, Los Angeles, Los Angeles, CA 
Area:
Virology Biology, Immunology
Tree Info Similar researchers PubMed Report error

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Peterson CW, Haworth KG, Burke BP, Polacino P, Norman KK, Adair JE, Hu SL, Bartlett JS, Symonds GP, Kiem HP. Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS. Molecular Therapy. Methods & Clinical Development. 3: 16007. PMID 26958575 DOI: 10.1038/Mtm.2016.7  0.573
2015 Burke BP, Levin BR, Zhang J, Sahakyan A, Boyer J, Carroll MV, Colón JC, Keech N, Rezek V, Bristol G, Eggers E, Cortado R, Boyd MP, Impey H, Shimizu S, et al. Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector. Molecular Therapy. Nucleic Acids. 4: e236. PMID 25872029 DOI: 10.1038/Mtna.2015.10  0.628
2015 Lee C, Burke B, Bartlett J. 469. Development and Characterization of GPRG-Based Producer Cell Lines for the Bioproduction of Lentiviral Vectors for HIV Gene Therapy Molecular Therapy. 23: S186. DOI: 10.1016/S1525-0016(16)34078-3  0.503
2014 Wolstein O, Boyd M, Millington M, Impey H, Boyer J, Howe A, Delebecque F, Cornetta K, Rothe M, Baum C, Nicolson T, Koldej R, Zhang J, Keech N, Camba Colón J, ... ... Burke B, et al. Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor. Molecular Therapy. Methods & Clinical Development. 1: 11. PMID 26015947 DOI: 10.1038/Mtm.2013.11  0.594
2014 Burke BP, Boyd MP, Impey H, Breton LR, Bartlett JS, Symonds GP, Hütter G. CCR5 as a natural and modulated target for inhibition of HIV. Viruses. 6: 54-68. PMID 24381033 DOI: 10.3390/V6010054  0.611
2012 Ringpis GE, Shimizu S, Arokium H, Camba-Colón J, Carroll MV, Cortado R, Xie Y, Kim PY, Sahakyan A, Lowe EL, Narukawa M, Kandarian FN, Burke BP, Symonds GP, An DS, et al. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice. Plos One. 7: e53492. PMID 23300932 DOI: 10.1371/Journal.Pone.0053492  0.644
2011 Marsden MD, Burke BP, Zack JA. HIV latency is influenced by regions of the viral genome outside of the long terminal repeats and regulatory genes. Virology. 417: 394-9. PMID 21777932 DOI: 10.1016/J.Virol.2011.06.024  0.57
2010 Symonds GP, Johnstone HA, Millington ML, Boyd MP, Burke BP, Breton LR. The use of cell-delivered gene therapy for the treatment of HIV/AIDS. Immunologic Research. 48: 84-98. PMID 20737298 DOI: 10.1007/S12026-010-8169-7  0.561
2007 Burke B, Brown HJ, Marsden MD, Bristol G, Vatakis DN, Zack JA. Primary cell model for activation-inducible human immunodeficiency virus. Journal of Virology. 81: 7424-34. PMID 17475639 DOI: 10.1128/Jvi.02838-06  0.591
2006 Galic Z, Kitchen SG, Kacena A, Subramanian A, Burke B, Cortado R, Zack JA. T lineage differentiation from human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America. 103: 11742-7. PMID 16844782 DOI: 10.1073/Pnas.0604244103  0.464
Show low-probability matches.